降钙素原在甲状腺髓样癌荷瘤鼠血清中的含量及相关性研究

doi:10.6040/j.issn.1673-3770.0.2020.157

摘要/Abstract

摘要： 目的探讨甲状腺髓样癌血清中降钙素原含量与作为MTC的肿瘤标志物的血清降钙素含量之间的关系。方法建立MTC荷瘤小鼠模型,检测小鼠血清中PCT及CT的含量,测量MTC瘤体的瘤质量和体积,分析PCT及CT与MTC肿瘤之间的相关性。结果 MTC荷瘤小鼠血清中PCT及CT的含量与瘤质量呈显著正相关;MTC荷瘤鼠血清中的PCT与CT含量呈显著正相关。结论 MTC荷瘤小鼠血清中PCT的含量与CT的含量具有一致性,PCT可以作为MTC的肿瘤标志物。

关键词: 甲状腺髓样癌, 降钙素原, 降钙素, 血清, 含量, 小鼠

Abstract: Objective To study the relationship between serum procalcitonin(PCT)and calcitonin(CT)levels in medullary thyroid carcinoma(MTC). Methods We evaluated the serum PCT and CT levels, tumor weight and volume, and bodyweight using MTC mice models to ascertain the relationship between serum PCT and CT and tumors. Results Serum PCT and CT in the group A mice were significantly and positively correlated with tumor weight; serum PCT and CT were also positively correlated. Conclusions This experiment demonstrates that serum PCT may be used as a tumor marker for MTC, in addition to serum CT, which has demonstrated utility for the diagnosis of MTC.

Key words: Medullary thyroid carcinoma, Procalcitonin, Calcitonin, Serum, Level, Mice

中图分类号:

R762

曾博,田兴德. 降钙素原在甲状腺髓样癌荷瘤鼠血清中的含量及相关性研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 86-91.

ZENG Bo, TIAN Xingde. Relationship between serum procalcitonin level of tumor-bearing mice and medullary thyroid carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 86-91.

参考文献

[1] 陈晓红. 遗传型甲状腺髓样癌的精准化治疗[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 23-27. doi: 10.6040/j.issn.1673-3770.1.2016.07. CHEN Xiaohong. Precision therapy on medullary thyroid carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2016, 30(2): 23-27. doi: 10.6040/j.issn.1673-3770.1.2016.07.
[2] Hadoux J, Pacini F, Tuttle RM, et al. Management of advanced medullary thyroid cancer[J]. Lancet Diabetes Endo, 2016, 4(1): 64-71. doi: 10.1016/S2213-8587(15)00337-X.
[3] 潘新良. 加强甲状腺结节及恶性肿瘤的规范治疗[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 1-11. doi: 10.6040/j.issn.1673-3770.1.2020.037. PAN Xinliang. Improving the standard treatments for thyroid nodules and malignant tumors[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 1-11. doi: 10.6040/j.issn.1673-3770.1.2020.037.
[4] 龚艳萍, 刘枫, 邹秀和, 等. 甲状腺髓样癌的诊治进展[J]. 中国普外基础与临床杂志, 2016, 23(5): 620-625. doi: 10.7507/1007-9424.20160168. GONG Yanping, LIU Feng, ZOU Xiuhe, et al. Progression of diagnosis and treatment of medullary thyroid carcinoma[J]. Chin J Bases Clin General Surg, 2016, 23(5): 620-625. doi: 10.7507/1007-9424.20160168.
[5] Allelein S, Ehlers M, Morneau C, et al. Measurement of basal serum calcitonin for the diagnosis of medullary thyroid cancer[J]. Horm Et Metab, 2018, 50(1): 23-28. doi:10.1055/s-0043-122237.
[6] 陈伟才. 降钙素和癌胚抗原联合检测应用于甲状腺髓样癌诊治的价值[J]. 深圳中西医结合杂志, 2018, 28(7): 19-21. doi: 10.16458/j.cnki.1007-0893.2018.07.008.
[7] Samà MT, Rossetto Giaccherino R, Gallo M, et al. Clinical challenges with calcitonin-negative medullary thyroid carcinoma[J]. J Cancer Res Clin Oncol, 2016, 142(9): 2023-2029. doi:10.1007/s00432-016-2169-5.
[8] Ittner L, Born W, Rau B, et al. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma[J]. European Journal of Endocrinology, 2002, 147(6): 727-731. doi: 10.1530/eje.0.1470727,
[9] 李逢将, 王凤, 苑鑫, 等. 通过降钙素原异常升高发现甲状腺髓样癌一例[J]. 中华肺部疾病杂志(电子版), 2017, 10(4): 495-496. doi: 10.3877/cma.j.issn.1674-6902.2017.04.033
[10] d'Herbomez M, Caron P, Bauters C, et al. Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking[J]. Eur J Endocrinol, 2007, 157(6): 749-755. doi:10.1530/EJE-07-0566.
[11] Saltiki K, Rentziou G, Stamatelopoulos K, et al. Small medullary thyroid carcinoma: post-operative calcitonin rather than tumour size predicts disease persistence and progression[J]. Eur J Endocrinol, 2014, 171(1): 117-126. doi:10.1530/EJE-14-0076.
[12] Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6): 567-610. doi:10.1089/thy.2014.0335.
[13] Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer[J]. J Clin Endocrinol Metab, 2010, 95(6): 2655-2663. doi:10.1210/jc.2009-2368.
[14] 徐书杭, 李春睿, 刘超. 儿童甲状腺癌的规范化诊治[J]. 山东大学耳鼻喉眼学报, 2017, 31(6): 12-15. doi: 10.6040/j.issn.1673-3770.1.2017.038. XU Shuhang, LI Chunrui, LIU Chao. Optimal management of differentiated thyroid carcinoma in children[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2017, 31(6): 12-15. doi: 10.6040/j.issn.1673-3770.1.2017.038.
[15] 季娟娟, 孙耕耘. 降钙素原和常用炎症指标在脓毒症诊断及预后中的价值[J]. 中华肺部疾病杂志(电子版), 2015, 8(4): 416-420. doi: 10.3877/cma.j.issn.1674-6902.2015.04.002. JI Juanjuan, SUN Gengyun. The diagnostic value and prognostic significance of serum procalcitonin and Common inflammatory markers in patients with sepsis[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2015, 8(4): 416-420. doi: 10.3877/cma.j.issn.1674-6902.2015.04.002.
[16] 高占成. 降钙素原对诊断慢性阻塞性肺疾病急性加重的应用价值[J]. 中华结核和呼吸杂志, 2013, 36(4): 313-314. doi: 10.3760/cma.j.issn.1001-0939.2013.04.025.
[17] 张立, 徐婷, 林勇. 降钙素原指导抗生素治疗策略在社区获得性下呼吸道感染中应用的荟萃分析[J]. 中华结核和呼吸杂志, 2012, 35(4): 275-282. doi: 10.3760/cma.j.issn.1001-0939.2012.04.012. ZHANG Li, XU Ting, LIN Yong. Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tractinfections: a systematic review and meta-analysis of randomized controlled trials[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2012, 35(4): 275-282. doi: 10.3760/cma.j.issn.1001-0939.2012.04.012.
[18] Bihan H, Becker KL, Snider RH, et al. Calcitonin precursor levels in human medullary thyroid carcinoma[J]. Thyroid, 2003, 13(8): 819-822. doi:10.1089/105072503768499716.
[19] Bolko P, Manuszewska-Jopek E, Michaek K, et al. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma[J]. Arch Immunol Ther Exp(Warsz), 2003, 51(6): 415-419.
[20] 赵岚, 崔天盆, 张家衡, 等. 甲状腺髓样癌血清降钙素原异常增高[J]. 中华检验医学杂志, 2015, 38(4): 283-284. doi: 10.3760/cma.j.issn.1009-9158.2015.04.017.
[21] Giovanella L, Imperiali M, Piccardo A, et al. Procalcitonin measurement to screen medullary thyroid carcinoma: a prospective evaluation in a series of 2705 patients with thyroid nodules[J]. Eur J Clin Invest, 2018, 48(6): e12934. doi:10.1111/eci.12934.
[22] 胡欣, 韩雪, 陈国芳, 等. 血清降钙素原在甲状腺髓样癌诊断及随访中的临床价值[J]. 临床内科杂志, 2020, 37(1): 69-70. doi: 10.3969/j.issn.1001-9057.2020.01.023.
[23] Woliński K, Kaznowski J, Klimowicz A, et al. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen[J]. Endokrynol Pol, 2017, 68(4): 434-437. doi:10.5603/EP.a2017.0038.
[24] Trimboli P, Seregni E, Treglia G, et al. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review[J]. Endocr Relat Cancer, 2015, 22(3): R157-R164. doi:10.1530/ERC-15-0156.
[25] Brutsaert EF, Gersten AJ, Tassler AB, et al. Medullary thyroid cancer with undetectable serum calcitonin[J]. J Clin Endocrinol Metab, 2015, 100(2): 337-341. doi:10.1210/jc.2014-3095.
[26] Giovanella L, Verburg FA, Imperiali M, et al. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules[J]. Clin Chem Lab Med, 2013, 51(7): 1477-1481. doi:10.1515/cclm-2012-0610.

相关文章 15

[1]	吉睿,刘雅洁,王佳琪,史雅文,张炜明,殷敏. 慢性间歇性缺氧对大鼠茎突舌肌的影响及作用机制[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 44-48.
[2]	周荷青,申琪. 中医药治疗变应性鼻炎疗效的生物标志物研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 168-176.
[3]	张竹萍,叶琪,郭蓓,林凌. 叶酸受体阳性循环肿瘤细胞检测在喉鳞状细胞癌诊断中的应用价值[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 50-53.
[4]	程雷,许秋艳,陈浩. 变态反应检测与诊断的临床应用及意义[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 1-6.
[5]	付奕豪,徐逸轩,严宏,张婕. 谷氧还蛋白在眼病中的作用研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(3): 125-130.
[6]	李健忠,周永锐,李慧英,李妙编,孙一涤,邱前辉. 彩超引导低温等离子消融术在甲状腺良性结节的临床应用研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 34-38.
[7]	罗露,周恩,欧阳思,陈义,肖旭平,王继华. 42例喉癌患者血清 microRNAlet-7a 水平的变化及意义[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 96-100.
[8]	王子熹,曲辉,王瑞琦,何海娟,关凯,刘杰,鹿道温. 青岛及北京地区五年间空气中豚草花粉的调查与分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 73-76.
[9]	姜晓丹,董庆喆,党志红,李慎玲,苗玉,赵涵,张念凯. 不同剂量外源性白介素17A干预对变应性鼻炎小鼠气道炎症的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 73-78.
[10]	浦洪波,杜晓东. 无锡地区2 000例变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 105-107.
[11]	邓月,徐亚平,彭浒,陶绮蕾,范静平,孙爱华,吴建. 铁必复颗粒治疗缺铁感音神经性聋患者的疗效分析[J]. 山东大学耳鼻喉眼学报, 2017, 31(1): 75-79.
[12]	金成勋,赵雪,刘悦,魏宁,金春顺. Kimura病11例并文献复习[J]. 山东大学耳鼻喉眼学报, 2016, 30(6): 63-66.
[13]	邰旭辉,杨昕,朱宝玉,曹鋐,褚彦玲,单晓东,姜宇. 辽宁地区2 883例变应性鼻炎患者变应原分布特征[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 39-42.
[14]	余鹏举, 许风雷, 杨军, 陈伟, 江满杰. 血浆1-3-β-D葡聚糖对真菌性鼻窦炎的诊断价值[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 94-97.
[15]	陈晓红. 遗传型甲状腺髓样癌的精准化治疗[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 23-27.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed